Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Lenalidomide versus thalidomide in myeloma

Prof Keith Stewart - Mayo Clinic, Scottsdale, USA

Lenalidomide versus thalidomide in myeloma ( Prof Keith Stewart - Mayo Clinic, Scottsdale, USA )

Comment: Advances in haematological cancer presented at EHA 2014

Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands

Comment: Advances in haematological cancer presented at EHA 2014 ( Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands )

Advances in mantle cell lymphoma: Expert discussion

Prof Simon Rule and Prof Franco Cavalli

Advances in mantle cell lymphoma: Expert discussion ( Prof Simon Rule and Prof Franco Cavalli )

Advances in chronic lymphocytic leukaemia: Expert panel discussion

Prof Peter Hillmen; Prof John Gribben; Prof Stephen Mulligan

Advances in chronic lymphocytic leukaemia: Expert panel discussion ( Prof Peter Hillmen; Prof John Gribben; Prof Stephen Mulligan )

Genetically modified T cells fight haematological cancer

Dr Roman Galetto - Cellectis Therapeutics, Paris, France

Genetically modified T cells fight haematological cancer ( Dr Roman Galetto - Cellectis Therapeutics, Paris, France )

Pivotal ruxolitinib data shows promise for patients with PV

Prof Alessandro Vannucchi - University of Florence, Florence, Italy

Pivotal ruxolitinib data shows promise for patients with PV ( Prof Alessandro Vannucchi - University of Florence, Florence, Italy )

Novel Bcl-2 specific inhibitor updated results confirm substantial activity and...

Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia

Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL ( Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia )

Does the use of generics of imatinib for chronic myeloid leukaemia jeopardise...

Dr Zafer Başlar - Istanbul University, Istanbul, Turkey

Does the use of generics of imatinib for chronic myeloid leukaemia jeopardise patient safety? ( Dr Zafer Başlar - Istanbul University, Istanbul, Turkey )

Ibrutinib improves survival in CLL and SLL patients, RESONATE study shows

Prof Peter Hillmen - St James’ University Hospital, Leeds, UK

Ibrutinib improves survival in CLL and SLL patients, RESONATE study shows ( Prof Peter Hillmen - St James’ University Hospital, Leeds, UK )

LHRH analogue goserelin helps preserve fertility among women undergoing chemo...

Dr Halle Moore - Taussig Cancer Institute, Cleveland, USA

LHRH analogue goserelin helps preserve fertility among women undergoing chemo for hormone receptor-negative breast cancer ( Dr Halle Moore - Taussig Cancer Institute, Cleveland, USA )

Investigating anticarcinogenic compounds as an alternative to chemo

Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy

Investigating anticarcinogenic compounds as an alternative to chemo ( Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy )

Importance of oncology nurses' work and research to cancer care

Sarah Liptrott - Eurpean Institute of Oncology, Milan, Italy

Importance of oncology nurses' work and research to cancer care ( Sarah Liptrott - Eurpean Institute of Oncology, Milan, Italy )

More from ecancer